文献速递细菌感染、耐药与抗菌药物医院感染防控

澳大利亚新南威尔士州ST45 MRSA spa基因缺失的多中心暴发

A multicentre outbreak of ST45 MRSA containing deletions in the spa gene in New South Wales, Australia.
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

该研究对澳大利亚新南威尔士州六家医院的131株ST45 MRSA进行全基因组测序分析,发现88.5%(116/131)存在spa基因缺失,该缺失约在2010年出现一次后克隆扩张。此缺失导致Cepheid Xpert® MRSA/SA BC检测出现假阴性,促使检测算法更新以应对spa缺失或SCCmec靶标变异。

要点

  • ST45 MRSA spa基因缺失可致Cepheid Xpert® MRSA/SA BC检测假阴性。
  • 新南威尔士州131株ST45 MRSA中88.5%携带spa缺失。
  • 全基因组测序可监测影响诊断的进化事件并指导修正。

核心结论

  • ST45 MRSA spa基因缺失克隆的成功建立使Cepheid Xpert® MRSA/SA BC检测在新南威尔士州用于确认金黄色葡萄球菌菌血症变得不可靠。

研究设计与样本

  • 收集澳大利亚新南威尔士州六家医院的131株ST45 MRSA的全基因组测序读段数据并进行分析。

主要发现

  • 131株ST45 MRSA中88.5%(116/131)含有spa基因缺失,该缺失似乎约在2010年出现一次,随后发生克隆扩张。

临床怎么用

  • 临床微生物实验室应知晓spa基因缺失可导致Cepheid Xpert® MRSA/SA BC检测假阴性,必要时采用其他方法确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early identification of MRSA by diagnostic medical microbiology laboratories enables improved antimicrobial choice and outcomes. The Cepheid Xpert® MRSA/SA BC test rapidly identifies Staphylococcus aureus bloodstream infections through spa gene detection and methicillin resistance via mecA gene detection. Recent emergence of S. aureus with deletions in the spa gene has resulted in false-negative results for this test, leading to misidentification of infections with this organism, particularly MRSA ST45. OBJECTIVES: To investigate the emergence and prevalence of ST45 MRSA in New South Wales (NSW), Australia. METHODS: WGS read data from six NSW hospitals were collected for 131 ST45 MRSA isolates and analysed. RESULTS: Of the 131 ST45 MRSA investigated, 88.5% (116/131) contained a deletion in the spa gene that appeared to have arisen once in approximately 2010 followed by clonal expansion. Given the successful establishment of this 'spa-deletion' MRSA clone, the Cepheid Xpert® MRSA/SA BC test became unreliable for confirming S. aureus bacteraemia in NSW. Subsequently, the algorithm used by this test has been updated and evaluated to take into account the presence of S. aureus with either a spa deletion or SCCmec target variations. CONCLUSIONS: This study highlighted the applied use of WGS for assessing diagnostic assays and informing necessary changes to ensure the viability of the Cepheid Xpert® MRSA/SA BC test in the context of the new 'spa-deletion' MRSA clone. It demonstrated how continued surveillance through WGS can reveal evolutionary events that may impact diagnostic assays, allowing corrective modifications to be made in real time.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Beukers AG, Newton P, Hudson B, et al. A multicentre outbreak of ST45 MRSA containing deletions in the spa gene in New South Wales, Australia. J Antimicrob Chemother. 2020. PMID: 32016400. doi:10.1093/jac/dkz560

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。